Brain Tumor Research 
The treatment of malignant brain tumors is an enormous clinical challenge. Many anticancer drugs cannot reach tumors because of the formidable blood-brain barrier, which prohibits the passage of large molecules. Other drugs do make it through this barrier, but are ineffective against malignant brain tumors, which often develop resistance to treatment. Advances in neuro-oncology can only be made through research to determine the fundamental biology of malignant brain tumors and clinical trials assessing new agents developed as a result of these findings.
The goal of the NYU Cancer Institute brain tumor translational research program is to identify more effective therapies that extend survival for patients with these diseases. The NYUCI offers clinical trials for patients with a variety of brain tumors.